Glucose Health (GLUC) vs. Its Peers Financial Survey

Glucose Health (OTCMKTS:GLUC) is one of 51 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its peers? We will compare Glucose Health to related companies based on the strength of its risk, earnings, profitability, analyst recommendations, dividends, institutional ownership and valuation.

Institutional & Insider Ownership

16.2% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 21.7% of shares of all “Medicinals & botanicals” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Glucose Health and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Glucose Health	-75.00%	N/A	N/A
Glucose Health Competitors	-42.21%	-22.72%	-7.72%

Analyst Recommendations

This is a breakdown of current ratings and target prices for Glucose Health and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glucose Health	0	0	0	0	N/A
Glucose Health Competitors	272	537	980	74	2.46

As a group, “Medicinals & botanicals” companies have a potential upside of 62.84%. Given Glucose Health’s peers higher possible upside, analysts plainly believe Glucose Health has less favorable growth aspects than its peers.

Valuation & Earnings

This table compares Glucose Health and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Glucose Health	$540,000.00	-$420,000.00	-8.67
Glucose Health Competitors	$325.05 million	-$49.38 million	-8.59

Glucose Health’s peers have higher revenue, but lower earnings than Glucose Health. Glucose Health is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

Glucose Health has a beta of 3.49, indicating that its stock price is 249% more volatile than the S&P 500. Comparatively, Glucose Health’s peers have a beta of 1.07, indicating that their average stock price is 7% more volatile than the S&P 500.

Summary

Glucose Health peers beat Glucose Health on 6 of the 10 factors compared.

Glucose Health Company Profile

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.